The studied effects of formed liposomes on A375 cells and tumor-bearing nude mice demonstrated that the released LCP moved to the cytoplasm, where it inhibits the activity of galectin-3, which enhanced the PDT effect of Ce6 in melanoma treatment, inhibited the ability to invade tumor cells and enhanced the immune effect of lymphocytes. The gene discussed is LGALS3; the disease is neoplasm.